FIA COVID-19 NAb

Fluorescence Immunoassay (FIA)

FIA COVID-19 NAb

Neutralizing antibody (Nab) test for COVID-19 virus (SARS-CoV-2) in human blood using fluorescence immunization (FIA)

78ba4cf8265fbde5220b741d2c938ccb_1708567401_87.png


Product features
  • CE mark
  • ​Getting results in 20 minutes
  • Simple and easy to use
  • Optimized for Point of Care with a small diagnostic kit and reader
  • Fluorescent immunoassay
  • High diagnostic accuracy
  • Economical and capable of mass testing
  •  Specification

    Specimen Serum
    Specimen volume 20㎕
    Test time 15 minutes
    Storage temperature 2-30℃
    Expiration date Refer to label for expiration date



  • COVID-19 disease caused by SARS-CoV-2 is a new respiratory infectious disease and was declared "pandemic" by the World Health Organization (WHO) in March 2020. Symptoms of the epidemic vary, but are mainly fatigue, high fever, and cough, and in more severe cases, breathing problems and severe lung damage. Although molecular diagnosis (genetic testing) is a standard diagnostic method for COVID-19, rapid antigen testing, which is easy to use, convenient, and field-testable, is widely used in many advanced countries, including the United States, Japan, and Europe.